According to research report the IVD Quality Control Market is projected to reach $1,158 million by 2025 from $961 million in 2020, at a CAGR of 3.8% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582
Some of the factors driving the growth of the In Vitro Diagnostics Quality Control Market are increasing number of accredited clinical laboratories, rising demand for external quality assurance support, and growing adoption of third-party quality controls.
The molecualr diagnostics segment is expected to grow at the highest CAGR during the forecast period.
Based on applications, the IVD quality control market is segmented into clinical chemistry, immunochemistry, hematology, coagulation & hemostasis, microbiology, molecular diagnostics, and other applications (ESR, urine chemistry, immunology, cardiac assessment, and blood morphology). The molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the rising prevalence of infectious diseases, cancer, and various genetic disorders; the growing demand for blood screening; and the increasing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing.
The serum/plasma based quality control segment is expected to dominate the market in 2019.
On the basis of type, the quality control products market is segmented into serum/plasma-based controls, whole blood-based controls, urine-based controls, and other controls (controls manufactured from spinal fluid, lipoprotein extracts, and immunoproteins). The serum/plasma-based controls segment is expected to account for the largest market share in 2019. The large share of this segment is mainly attributed to the greater uptake of serum/plasma-based quality controls among laboratories and the widening application areas of these controls for various IVD tests.
The North America to hold the largest regional market share in 2020.
The North America is expected to account for the largest share of the global IVD quality control market in 2020, followed by Europe. The large share of the North America can be attributed to the highly developed healthcare system in the US and Canada, and the presence of a large number of leading IVD quality control vendors & national clinical laboratories & hospitals in this region.
Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=198032582
The prominent players in this market are Bio-Rad Laboratories Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific Inc. (US), Technopath Clinical Diagnostics (Ireland), Bio-Techne Corporation (US), Fortress Diagnostics (UK), SeraCare Life Sciences Inc. (US), SERO AS (Norway), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), and Abbott Laboratories Inc. (US).
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
[email protected]
IVD Quality Control Market worth USD 1,158 Million by 2025
According to research report the global IVD quality control market is expected to reach USD 1.04 billion by 2022, at a CAGR of 3.5% from 2017 to 2022.
The global IVD quality controls market is oligopolistic in nature with very few players accounting for a major share of the market.
Bio-Rad Laboratories, Inc. (U.S.), Randox Laboratories (U.K.), and Thermo Fisher Scientific, Inc. (U.S.) are the major players in this market.
A majority of the leading players in this market are based in developed countries across North America and Europe.Read more: https://www.marketsandmarkets.com/PressReleases/in-vitro-diagnostics-quality-controls.aspIn 2016, Bio-Rad Laboratories held the leading position in the IVD quality controls market.
This can be attributed to its highly diversified quality controls portfolio, which includes controls for immunoassay, therapeutic drug monitoring, serum chemistry, and urine chemistry; urinalysis controls; cardiac assessment quality controls; immunology/protein controls; hematology, blood gas, diabetes/hemoglobin, and infectious disease controls; molecular quality controls; and specialty quality controls.
The company also offers third party quality controls, data management solutions, educational services, and customer support to clinical laboratories.In 2016, Randox Laboratories held the second largest share of the IVD quality controls market.
Global In Vitro Diagnostics (IVD) Quality Control Market Overview:Today’s businesses choose the market research report solution such as In Vitro Diagnostics (IVD) Quality Control Market report because it lends a hand with the improved decision making and more revenue generation.
Industry tendencies, the growth proportion of major producers, and production analysis are the segments included in the chapter of global growth trends of In Vitro Diagnostics (IVD) Quality Control business report.
While studying Market size by application it covers Market consumption analysis by application whereas studying Market size by type includes analysis of value, product utility, Market percentage, and production Market share by type.The persuasive In Vitro Diagnostics (IVD) Quality Control Market report is all-embracing of the data which covers Market definition, classifications, applications, engagements, Market drivers, and Market restraints that are based on the SWOT analysis.
Analysis of profiles of manufacturers or commanding players of the global Market is performed based on sales area, key products, gross margin, revenue, price, and production.
The chapter of Market value chain and sales channel analysis of this Market document includes details of customer, distributor, Market value chain, and sales channel analysis.
An excellent In Vitro Diagnostics (IVD) Quality Control report consists of most recent Market information with which companies can attain in depth analysis of Healthcare industry and future trends.Available Exclusive Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-in-vitro-diagnostics-ivd-quality-control-market .The Global In Vitro Diagnostics (IVD) Quality Control Market to account to USD 1.25 Billion by 2027 growing at a CAGR of 3.8% in the forecast period of 2020 to 2027.According to the market report analysis, In-vitro diagnostics (IVDs) are those medical devices and accessories which are specially designed so they can conduct in-vitro testing on body samples such as tissues, blood and urine.
According to research report the global IVD quality control market is expected to reach USD 1.04 billion by 2022, at a CAGR of 3.5% from 2017 to 2022.
The global IVD quality controls market is oligopolistic in nature with very few players accounting for a major share of the market.
Bio-Rad Laboratories, Inc. (U.S.), Randox Laboratories (U.K.), and Thermo Fisher Scientific, Inc. (U.S.) are the major players in this market.
A majority of the leading players in this market are based in developed countries across North America and Europe.Read more: https://www.marketsandmarkets.com/PressReleases/in-vitro-diagnostics-quality-controls.aspIn 2016, Bio-Rad Laboratories held the leading position in the IVD quality controls market.
This can be attributed to its highly diversified quality controls portfolio, which includes controls for immunoassay, therapeutic drug monitoring, serum chemistry, and urine chemistry; urinalysis controls; cardiac assessment quality controls; immunology/protein controls; hematology, blood gas, diabetes/hemoglobin, and infectious disease controls; molecular quality controls; and specialty quality controls.
The company also offers third party quality controls, data management solutions, educational services, and customer support to clinical laboratories.In 2016, Randox Laboratories held the second largest share of the IVD quality controls market.
Global In Vitro Diagnostics (IVD) Quality Control Market Overview:Today’s businesses choose the market research report solution such as In Vitro Diagnostics (IVD) Quality Control Market report because it lends a hand with the improved decision making and more revenue generation.
Industry tendencies, the growth proportion of major producers, and production analysis are the segments included in the chapter of global growth trends of In Vitro Diagnostics (IVD) Quality Control business report.
While studying Market size by application it covers Market consumption analysis by application whereas studying Market size by type includes analysis of value, product utility, Market percentage, and production Market share by type.The persuasive In Vitro Diagnostics (IVD) Quality Control Market report is all-embracing of the data which covers Market definition, classifications, applications, engagements, Market drivers, and Market restraints that are based on the SWOT analysis.
Analysis of profiles of manufacturers or commanding players of the global Market is performed based on sales area, key products, gross margin, revenue, price, and production.
The chapter of Market value chain and sales channel analysis of this Market document includes details of customer, distributor, Market value chain, and sales channel analysis.
An excellent In Vitro Diagnostics (IVD) Quality Control report consists of most recent Market information with which companies can attain in depth analysis of Healthcare industry and future trends.Available Exclusive Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-in-vitro-diagnostics-ivd-quality-control-market .The Global In Vitro Diagnostics (IVD) Quality Control Market to account to USD 1.25 Billion by 2027 growing at a CAGR of 3.8% in the forecast period of 2020 to 2027.According to the market report analysis, In-vitro diagnostics (IVDs) are those medical devices and accessories which are specially designed so they can conduct in-vitro testing on body samples such as tissues, blood and urine.